68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas
-
Published:2023-05-15
Issue:6
Volume:73
Page:1340-1343
-
ISSN:0030-9982
-
Container-title:Journal of the Pakistan Medical Association
-
language:
-
Short-container-title:J Pak Med Assoc
Author:
Sharjeel Usmani ,Anjali Jain ,Syed Furqan Hashmi ,Layth Mula-Hussain ,Khulood Al Riyami ,Sofiullah Abubakar ,Muhammad Shahzad Shamim
Abstract
Meningiomas overexpress somatostatin receptors (SSTR). PET imaging with SSTR ligands such as 68Ga-DOTA-peptide has recently shown high diagnostic accuracy in identification of meningiomas due to lack of normal bone and brain activity. PET-derived parameters, especially gross tumour volume (GTV) delineation improves inter-observer variability and appears to be particularly promising for RT planning. The potential strength of 68Ga-DOTA in the ongoing assessment of treatment response and disease progression in meningioma, particularly in the post-surgical and post-radiation settings is encouraging. More prospective randomized studies with large cohorts of patients are required to define the effective role of this modality.
Keywords: 68Ga-DOTA PET/CT; Meningioma; 177Lu-DOTATATE; PET/CT; radiotherapy planning.
Publisher
Pakistan Medical Association